维普中文期刊产品整合服务
64篇 您的检索式:作者名="Stone NN"
    题名 作者 年代 出处 被引量
1Complications following permanent prostate brachytherapy 显示文摘Stone NN Stock RG 2002European urology2002,41,4:1
2Prostate brachytherapy: treatment strategies 显示文摘Stone NN Stock RG 1999J Urol1999,162,:1
3Complications following permanent prostate brachytherapy显示文摘Stone NN Stock RG 2002Eur Urol2002,,41:1
4Prostate brachytherapy : treatment strategies 显示文摘Stone NN Stock RG 1999J Urol1999,162,:1
5Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy显示文摘Kollmeier MA Stock RG Cesaretti J Stone NN 2005J Urol2005,173,3:1
6Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high risk prostate cancer 显示文摘Ferrari AC Stone NN Eyler JN 1997J Natl Cancer Inst1997,89,20:1
7Disease-specific survival following the brachytherapy management of prostate cancer 显示文摘Stock RG Cesaretti JA Stone NN 2006Int J Radiat Oncol Biol Phys2006,64,3:1
8A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation 显示文摘Stock RG Stone NN Wesson MF 1995Int J Radiat Oncol Biol Phys1995,32,1:1
9Complications following permanent prostate brachytherapy显示文摘Stone NN Stock RG 2002Eur Urol2002,41,:1
10Intermediate term biochemicalfree progression and local control following 125 iodine brachytherapy for prostate cancer 显示文摘Stone NN Stock RG Unger P 2005J Urol2005,173,3:1
11Comparison of perspectives on prostate cancer: analyses of survey data 显示文摘Crawford ED Bennett CL Stone NN 1997Urology1997,50,3:1
12Intermediate term biochemical-free progression and local control following 125 iodine brachytherapy for prostate cancer显示文摘Stone NN ’ Stock RG U hger P 2005J Urol2005,173,3:1
13Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation 显示文摘Stone NN Ratnow ER Stock RG 2000Tech Urol2000,6,2:1
14Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years 显示文摘Stone NN Stock RG 2007Urology2007,69,2:1
15Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy 显示文摘Stone NN Potters L Davis BJ 2009Int J Radiat Oncol Bioi Phys2009,73,2:1
16Urinary symptomflare following I 125 prostate brachytherapy显示文摘CESARETTI JA STONE NN ST0CKRG 2003Int JRadiat Oncol Biol Phys2003,56,11:1
17Complications following permanent Prostate brachytherapy显示文摘Stone NN Stock RG 2002Eur Urol2002,41,4:1
18A dose-response study for Ⅰ-125 prostate implants显示文摘Stock RG Stone NN Tabert A 1998Int J Raidat Oncol Bilo Phys1998,41,1:1
19Customized dose prescription for permanent prostate brachytherapy , insights from a multicenter analysis of dosimetry outcomes 显示文摘Stone NN Potters L Davis BJ 2007Int J Radiat Oncol Bioi Phys2007,69,5:1
20Role of hormonal therapy in the management of intermediate to high-risk prostate cancer treated with permanent radioactive seed implantation 显示文摘Lee LN Stock RG Stone NN 2002Int J Radiat Oncol Biol Phys2002,52,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费